The ROCA® Test
for Ovarian Cancer

Determines a woman’s risk of having ovarian cancer.

Learn Now

Women coping with ovarian cancer

The Importance of Early Detection


women in the UK are diagnosed with ovarian cancer every day.1


most common cause of cancer-related deaths in women in the UK.2


of women survive for at least 5 years if cancer is caught in the earliest stage.3


of women survive 5 years if cancer caught in the latest stage.3


The ROCA Test is intended for women who are between 50 and 85 years old and have been through menopause, or between 35 and 85 years old with a family history of ovarian and/or breast cancer, are of Ashkenazi Jewish descent with a known family history of ovarian or breast cancer, or have tested positive for BRCA1, BRCA2 or Lynch syndrome gene mutation.

Learn more about the ROCA Test

Latest News

Clarification from trialists about FDA recommendation on ovarian cancer screening tests

Researchers from the UKCTOCS and UK FOCSS trials provide a response to clarify results after the U.S. FDA releases a statement on ovarian cancer screening.

Read more

Abcodia Statement on the ROCA Test for Ovarian Cancer Screening

Abcodia has released a response to the FDA's statement on ovarian cancer screening released on 7 Sept 2016. Notwithstanding our confidence in the clinical utility of the ROCA Test, we have voluntarily decided to temporarily limit the availability of the ROCA Test in the United Kingdom.

Read more